Maryanne Demasi, PhD ✓
@MaryanneDemasi · Sydney · joined 28 Mar 2011
Investigative journalist, PhD, Researcher, TV presenter/producer, ex-@ABCTV. @Brownstoneinst Fellow. Subscribe to my Substack 👇🏼
66 610Followers
1 534Following
12 378Posts total
711.3KViews on collected posts
Latest posts
Looking for new posts…
🥂 4 yrs ago, I had no idea where any of this would lead. I’m very glad I took the chance.
Thank you to my subscribers & to @brownstoneinst for your continued support.
If you haven't signed up -- please do 👇👇
https://t.co/pvSYkU5S0q https://t.co/hSn4Tsbbep
10.2K views · 106 likes
· 19 reposts · 7 replies
Open on X →
🚩ACIP has been frozen for over 5 months - so who makes the decisions now?
FDA is still approving new vaccines while ACIP remains paralysed. The question is what happens next.
LINK 👇👇
@SecKennedy @CDCDirector @NIHDirector_Jay https://t.co/U1otAnR6dI
3.7K views · 44 likes
· 10 reposts · 8 replies
Open on X →
@MaryanneDemasi @SecKennedy @AnilMakam @Holden_Culotta @ProfTimNoakes @newstart_2024 @jeffreytucker @ClareCraigPath @MaryBowdenMD @P_McCulloughMD @Jikkyleaks @DrJulieSladden @kenjaques @Fynnderella1 @Humanspective @CatherineRiva Please remove the liability protections and this al
352 views · 16 likes
· 2 reposts · 1 replies
Open on X →
Pandemics will always create pressure to act quickly & governments cannot wait for perfect evidence before making every decision. But spending billions on medicines and administering them to millions of people should come with an obligation to find out whether they actually
1.3K views · 54 likes
· 12 reposts · 4 replies
Open on X →
During Covid, antiviral drugs again arrived amid urgency, political pressure and enormous demand for treatments. Remdesivir, molnupiravir, paxlovid -- all turned out to have little to no efficacy, and cause harm.
https://t.co/vpJfKFuK2d
https://t.co/kj3U33JIW3 https://t.co/74UqI
1.2K views · 49 likes
· 15 reposts · 2 replies
Open on X →
After years of pressure, @Roche eventually released the underlying material. When Cochrane reassessed the fuller evidence base, the picture changed significantly.
Cochrane’s updated analysis found that Tamiflu shortened symptoms by less than a day, but did not reduce https://t.co
743 views · 40 likes
· 5 reposts · 1 replies
Open on X →
Two decades ago, much of the evidence supporting Tamiflu remained in the hands of its manufacturer, @Roche & had never been published - the company refused to release the data, citing patient confidentiality concerns. Cochrane then joined forces with @bmj_latest, whose EIC at the
863 views · 45 likes
· 6 reposts · 2 replies
Open on X →
Until now, no randomised trial had compared Tamiflu with no antiviral in critically ill patients.
The international REMAP-CAP trial has now done that—and found no benefit. More patients died with Tamiflu than without it. https://t.co/3L2wq2w7US
1.6K views · 72 likes
· 12 reposts · 4 replies
Open on X →
💥The Tamiflu scam 💥
A randomised trial that should have been done decades ago has found more deaths among critically ill flu patients given Tamiflu than among those given no antiviral.
LINK below 👇
@SecKennedy @AnilMakam @Holden_Culotta
@ProfTimNoakes @newstart_2024 https://t.c
45.6K views · 364 likes
· 174 reposts · 13 replies
Open on X →
📢A new 'risk calculator' for heart disease - who should take statins?
There's a push to lower the threshold for prescribing statins....but
@RFRedberg @DrJohnAbramson, and I explain why prescribing more statins is not the answer.
https://t.co/OZJTaVup7K https://t.co/VTeZUxXwUY
6.9K views · 70 likes
· 12 reposts · 3 replies
Open on X →
@MaryanneDemasi @JAMAInternalMed And to prove my point. Not more than 1 hour ago I liked and reposted this post and come back later and my like had been deleted. https://t.co/E7wQLXw5B1
5.4K views · 49 likes
· 5 reposts · 4 replies
Open on X →
STATIN WARS: have we been misled by the evidence? Published in 2018 by BMJ’s BJSM. @BJSM_BMJ
https://t.co/s1r6XxVeNy https://t.co/tCxvOIdwfh
16.9K views · 233 likes
· 55 reposts · 13 replies
Open on X →
Scientific Censorship - read what led to the unravelling of scientific journalism at ABC TV and the prolonged, orchestrated attacks on those challenging orthodoxy.
https://t.co/nNlNUTxlPG https://t.co/Bl1m29sTXK
17.1K views · 180 likes
· 36 reposts · 8 replies
Open on X →
Here is a documentary I produced about cholesterol, statins and heart disease, which led to powerful vested interests calling for its censorship. Featuring @RFRedberg @DrJohnAbramson & more
https://t.co/IoR1K2vFVO https://t.co/qXpjsqGTtF
20.5K views · 381 likes
· 105 reposts · 13 replies
Open on X →
Experts proposed that #statins should be available over the counter.
Cardiologist Robert DuBroff and I disagree. 👇🏼
https://t.co/09Bi9HibFM https://t.co/uq7NsN2GQO
17.7K views · 150 likes
· 24 reposts · 5 replies
Open on X →
Do statins cause muscle aches?
~ 50% of patients stop their statins within 1yr of commencing therapy, mostly because of muscle problems.
But a major study published in @TheLancet concluded that statins are rarely to blame.
See why I disagree https://t.co/A4wHL2Emcu https://t.
19.6K views · 207 likes
· 46 reposts · 12 replies
Open on X →
Proposed guidelines in the UK recommend #statins to all adults if “the person is happy to take a statin”.
Here’s why it’s a bad idea 👇🏼
https://t.co/XrXFDxi989 https://t.co/fL7SjYXw9f
21.6K views · 222 likes
· 47 reposts · 7 replies
Open on X →
We respond to a critique by @PeterAttiaMD of our systematic review and meta analysis of #statin trials
https://t.co/aZuNWQ9Cc9 https://t.co/ndBuZYTh5T
23.9K views · 207 likes
· 29 reposts · 14 replies
Open on X →
🧵 Thread on my statin research 👇🏼
Our analysis in @JAMAInternalMed
21 statin trials, 143,532 participants
The benefits of #statins were minimal & most trial participants who took statins, derived no clinical benefit.
Reducing LDL-C with statins showed an inconsistent/weak ht
496.2K views · 2.8K likes
· 1.1K reposts · 153 replies
Open on X →
Against accounts of the same size
9 posts from the last 90 days, next to the 10K–100K follower range. reaches fewer people than peers, but engages them much harder.
Median views1 285this account924median for 10K–100K
Reach, %1.93%this account3.62%median for 10K–100K
Engagement, %5.40%this account1.52%median for 10K–100K
| Metric | This account | Median for 10K–100K | Ratio |
|---|---|---|---|
| Median views per post | 1 285 | 924 | 1.39× |
| Reach (views ÷ followers) | 1.93% | 3.62% | 0.53× |
| Engagement rate | 5.40% | 1.52% | 3.55× |
Others in this range → Compare with another account → How these benchmarks are built →
Growth & engagement
How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.
Views per post
20.5K5 May
17.1K
16.9K
5.4K28 Nov
6.9K21 Feb
45.6K27 Aug
1.6K
863
743
1.2K
1.3K
352
3.7K30 Aug
10.2K1 Sep
Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.
Engagement rate per post
2.46%5 May
1.32%
1.81%
1.10%28 Nov
1.23%21 Feb
1.27%27 Aug
5.54%
6.14%
6.19%
5.36%
5.60%
5.40%
1.73%30 Aug
1.31%1 Sep
Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.
What the audience does
Likes53.1%5 292 in total
Reposts17.4%1 734 in total
Replies2.7%274 in total
Quotes1.7%166 in total
Bookmarks25.1%2 502 in total
Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.
The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.
Similar accounts
Jonathan Jones
@jjones9
133.2K followers
· 84.8K posts
kiyana ✓
@empress_kiyana
133.2K followers
· 3.1K posts
Master.dev (Formerly Frontend Masters) ✓
@MasterDotDev
133.2K followers
· 13.4K posts
Estadão Esportes
@EstadaoEsporte
133.2K followers
· 219.5K posts
✈️ ✓
@Arrizabalager
133.2K followers
· 123K posts
Cabral LIBII
@CabralLibii
133.2K followers
· 3K posts
SF Examiner
@sfexaminer
133.2K followers
· 121.5K posts
Carol Challis
@BeingBoycie
133.2K followers
· 204.4K posts